HIGHER: Evofem (EVFM), up 18% after the AMPOWER Phase 3 trial met its primary endpoint… Axovant Sciences (AXON), up 14% after Jefferies analyst Michael Yee upgraded the stock to Buy and raised his price target for the shares to $3.00. Data readouts over the next year could drive a “meaningful percentage” return for small cap investors and take Axovant shares to $3 from $1 in 2019, Yee tells investors… Barnes & Noble (BKS), up 5% after Craig-Hallum analyst Alex Fuhrman upgraded the stock to Buy and raised his price target to $10 from $7. In a research note to investors, the analyst says initial Q4 checks have indicated improved results, continued cost controls and better holiday sales results, which, combined with the ongoing sales process, should provide “intriguing” upside potential… Jack in the Box (JACK), up 5% after announcing it is exploring strategic, financing alternatives. LOWER: Weatherford (WFT), down 2% after $50M sale of surface data logging business… Best Buy (BBY), down 6% after BofA Merrill Lynch analyst Curtis Nagle downgraded the stock to Underperform from Neutral, citing his caution about key product categories that include TVs, Apple (AAPL) products and gaming… Tenet (THC), down 7% after being downgraded to Neutral from Outperform at Baird… Centene (CNC), down 7% after Goldman Sachs removed the stock from the Conviction Buy List and lowered its price target to $144 from $155 to reflect risk associated with a potential adverse outcome in the Texas versus United States ACA ruling… Goldman Sachs (GS), down 2% after the Wall Street Journal reports Malaysian authorities have filed criminal charges against the bank.